Stock listing
gettex:6IO Inogen, Inc Aktie
German listing (gettex) of Inogen, Inc · home listing NASDAQ:INGN
Follow Inogen, Inc into a list and get an email when it puts out news.
Home listing price · NASDAQ:INGN
$5.30 USD -0.27 (-4.8%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:INGN
- Day range
- $5.24 – $5.68 USDNov 20, 2026
- Volume
- 351,928 sharesNov 20, 2026
- Market cap
- $140.7M USDAt the close on Nov 20, 2026 · price × 26.54M shares outstanding
- 52-week range
- $5.05 – $7.67 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1.82M USDMedian day 257,599 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:INGN · Home | $5.30 USD | -0.27 (-4.8%) | 351,928 | $5.40 | $5.675 | $5.24 | $5.57 | Close on Nov 20, 2026 |
| Frankfurt:6IO | €4.86 EUR | -0.19 (-3.8%) | — | €4.86 | €4.86 | €4.86 | €5.05 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:INGN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.30 | -0.27 | -4.8% | $5.40 | $5.675 | $5.24 | 351,928 | |
| $5.57 | -0.115 | -2.0% | $5.63 | $5.76 | $5.52 | 190,700 | |
| $5.685 | +0.055 | +1.0% | $5.58 | $5.73 | $5.52 | 172,747 | |
| $5.63 | -0.06 | -1.1% | $5.67 | $5.68 | $5.51 | 238,532 | |
| $5.69 | +0.07 | +1.2% | $5.60 | $5.71 | $5.55 | 238,116 | |
| $5.62 | -0.13 | -2.3% | $5.73 | $5.905 | $5.61 | 195,038 | |
| $5.75 | -0.25 | -4.2% | $6.00 | $6.01 | $5.685 | 286,145 | |
| $6.00 | -0.115 | -1.9% | $6.07 | $6.07 | $5.765 | 251,428 | |
| $6.115 | +0.085 | +1.4% | $5.99 | $6.21 | $5.865 | 391,619 | |
| $6.03 | -0.74 | -10.9% | $5.08 | $6.352 | $5.05 | 974,905 | |
| $6.77 | -0.45 | -6.2% | $7.28 | $7.33 | $6.67 | 284,973 | |
| $7.22 | +0.20 | +2.8% | $7.13 | $7.44 | $7.13 | 289,497 | |
| $7.02 | +0.15 | +2.2% | $6.90 | $7.04 | $6.737 | 201,830 | |
| $6.87 | +0.01 | +0.1% | $6.94 | $7.205 | $6.86 | 339,493 | |
| $6.86 | -0.40 | -5.5% | $7.30 | $7.30 | $6.69 | 201,105 | |
| $7.26 | +0.01 | +0.1% | $7.34 | $7.365 | $7.24 | 257,599 | |
| $7.25 | +0.12 | +1.7% | $7.20 | $7.30 | $7.15 | 281,186 | |
| $7.13 | +0.05 | +0.7% | $7.08 | $7.21 | $7.05 | 199,609 | |
| $7.08 | -0.02 | -0.3% | $7.00 | $7.09 | $6.973 | 191,783 | |
| $7.10 | +0.06 | +0.9% | $7.02 | $7.16 | $6.98 | 239,248 | |
| $7.04 | +0.37 | +5.5% | $6.67 | $7.15 | $6.67 | 514,176 | |
| $6.67 | -0.02 | -0.3% | $6.65 | $6.79 | $6.56 | 185,906 | |
| $6.69 | +0.14 | +2.1% | $6.55 | $6.71 | $6.495 | 229,027 | |
| $6.55 | +0.30 | +4.8% | $6.25 | $6.59 | $6.25 | 235,192 | |
| $6.25 | -0.045 | -0.7% | $6.30 | $6.38 | $6.225 | 193,900 | |
| $6.295 | +0.165 | +2.7% | $6.28 | $6.373 | $6.20 | 161,100 | |
| $6.13 | -0.21 | -3.3% | $6.26 | $6.32 | $6.05 | 348,900 | |
| $6.34 | -0.08 | -1.2% | $6.44 | $6.505 | $6.32 | 293,100 | |
| $6.42 | +0.24 | +3.9% | $6.17 | $6.45 | $6.16 | 236,900 | |
| $6.18 | +0.24 | +4.0% | $5.93 | $6.28 | $5.93 | 243,900 | |
| $5.94 | +0.12 | +2.1% | $5.79 | $5.94 | $5.74 | 454,400 | |
| $5.82 | +0.05 | +0.9% | $5.71 | $5.88 | $5.71 | 218,300 | |
| $5.77 | -0.17 | -2.9% | $5.94 | $5.98 | $5.765 | 352,900 | |
| $5.94 | -0.03 | -0.5% | $5.95 | $6.12 | $5.84 | 349,000 | |
| $5.97 | -0.01 | -0.2% | $6.05 | $6.05 | $5.82 | 426,800 | |
| $5.98 | +0.71 | +13.5% | $5.54 | $6.155 | $5.54 | 1,105,000 | |
| $5.27 | -0.10 | -1.9% | $5.39 | $5.39 | $5.265 | 263,400 | |
| $5.37 | -0.07 | -1.3% | $5.44 | $5.45 | $5.32 | 232,000 | |
| $5.44 | +0.08 | +1.5% | $5.36 | $5.50 | $5.33 | 301,900 | |
| $5.36 | +0.13 | +2.5% | $5.25 | $5.395 | $5.20 | 615,400 | |
| $5.23 | +0.14 | +2.8% | $5.10 | $5.29 | $5.05 | 433,600 | |
| $5.09 | -0.14 | -2.7% | $5.22 | $5.29 | $5.045 | 530,300 | |
| $5.23 | +0.13 | +2.5% | $5.14 | $5.295 | $5.105 | 437,900 | |
| $5.10 | -0.04 | -0.8% | $5.18 | $5.18 | $5.075 | 350,200 | |
| $5.14 | +0.01 | +0.2% | $5.10 | $5.18 | $5.09 | 439,000 | |
| $5.13 | 0.00 | 0.0% | $5.17 | $5.205 | $5.055 | 442,700 | |
| $5.13 | -0.07 | -1.3% | $5.19 | $5.27 | $5.095 | 442,100 | |
| $5.20 | -0.03 | -0.6% | $5.23 | $5.26 | $5.16 | 390,700 | |
| $5.23 | -0.08 | -1.5% | $5.30 | $5.42 | $5.23 | 311,000 | |
| $5.31 | +0.13 | +2.5% | $5.22 | $5.35 | $5.185 | 249,000 | |
| $5.18 | -0.09 | -1.7% | $5.23 | $5.258 | $5.155 | 243,400 | |
| $5.27 | +0.04 | +0.8% | $5.19 | $5.30 | $5.18 | 203,800 | |
| $5.23 | -0.19 | -3.5% | $5.48 | $5.54 | $5.20 | 316,500 | |
| $5.42 | -0.03 | -0.6% | $5.40 | $5.47 | $5.37 | 216,600 | |
| $5.45 | +0.06 | +1.1% | $5.41 | $5.50 | $5.293 | 272,900 | |
| $5.39 | +0.06 | +1.1% | $5.34 | $5.47 | $5.34 | 249,500 | |
| $5.33 | -0.04 | -0.7% | $5.35 | $5.45 | $5.32 | 247,000 | |
| $5.37 | -0.13 | -2.4% | $5.46 | $5.49 | $5.33 | 306,600 | |
| $5.50 | -0.01 | -0.2% | $5.53 | $5.66 | $5.46 | 200,200 | |
| $5.51 | -0.05 | -0.9% | $5.50 | $5.60 | $5.50 | 197,400 | |
| $5.56 | +0.02 | +0.4% | $5.51 | $5.585 | $5.453 | 230,900 | |
| $5.54 | +0.04 | +0.7% | $5.51 | $5.59 | $5.48 | 166,314 | |
| $5.50 | -0.11 | -2.0% | $5.62 | $5.66 | $5.50 | 333,491 | |
| $5.61 | +0.01 | +0.2% | $5.64 | $5.66 | $5.605 | 140,400 | |
| $5.60 | -0.08 | -1.4% | $5.65 | $5.706 | $5.59 | 207,300 |
- Ticker
- gettex:6IO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Nov 5, 2026
Inogen Announces Third Quarter 2026 Financial Results
Latest earnings call · Nov 5, 2026
Inogen (NASDAQ:INGN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Investor Presentation (November 2026)
Investor deck · 18 slides
Latest news
Inogen Announces Third Quarter 2026 Financial Results
Nov 5, 2026
Closed $6.03 (-10.9%) on Nov 6, 2026
Inogen Announces Leadership Transition
Nov 5, 2026
Closed $6.03 (-10.9%) on Nov 6, 2026
Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026
Oct 15, 2026
Closed $6.30 (+2.7%) on Oct 15, 2026
Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech
Sep 30, 2026
Closed $5.98 (+13.5%) on Oct 1, 2026
Inogen Announces Second Quarter 2026 Financial Results
Aug 6, 2026
Closed $6.05 (-6.8%) on Aug 7, 2026
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026
Jul 16, 2026
Closed $6.66 (+3.9%) on Jul 16, 2026
Inogen Announces the Appointment of Andy Reding as Chief Operating Officer
Jul 1, 2026
Closed $6.60 (-0.8%) on Jul 2, 2026
Inogen Announces First Quarter 2026 Financial Results
May 7, 2026
Closed $7.02 (-2.4%) on May 8, 2026
Inogen to Report First Quarter 2026 Financial Results on May 7, 2026
Apr 23, 2026
Closed $6.99 (-2.2%) on Apr 23, 2026
Inogen Announces the Appointment of Vafa Jamali to Board of Directors
Apr 6, 2026
Closed $6.36 (+2.4%) on Apr 6, 2026
Inogen, Inc on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 18 in the last 12 months · 125 in all · newest Nov 5, 2026 · oldest 2019
- Calls
- 22 calls with a replay · 22 with a transcript · latest Nov 5, 2026
- Decks
- 26 decks · latest Nov 5, 2026
Where Inogen, Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:INGN · Home listing | NASDAQ | United States | USD |
| LS Exchange:A1XB32 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1XB32 | Lang & Schwarz | Germany | EUR |
| gettex:6IO · This page | gettex | Germany | EUR |
| BOATS:INGN | BOATS | United States | USD |
| BX Swiss:6IO | BX Swiss | Switzerland | CHF |
| Dusseldorf:6IO | Dusseldorf | Germany | EUR |
| Frankfurt:6IO | Frankfurt | Germany | EUR |
| Stuttgart:6IO | Stuttgart | Germany | EUR |
| Tradegate:6IO | Tradegate | Germany | EUR |
Valuation
EV/sales 0.2× against a median of 3.4×: 3rd lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $58.75M USD
- P/E
- Loss
- EV/sales
- 0.2×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.9×
- Gross margin
- 44.1%
- Operating margin
- −11.6%
- Net margin
- −10.1%
- Debt to equity
- 0.1×
- Beta vs S&P 500
- 0.64
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Inogen, Inc · NASDAQ:INGN | US$140.7M | US$58.75M | n/a | 0.2× | n/a | 0.9× | −10.1% | 0.1× | 0.64 |
| PW Medtech Group Ltd. · HKEX:1358 | US$156.6M | −US$114.6M | 11.1× | −0.9× | −2.9× | 0.3× | 11.5% | 0.0× | n/a |
| CUREXO Inc. · KRX:060280 | US$152.5M | US$133.1M | 37.2× | 2.3× | 29.7× | 2.0× | 7.1% | 0.0× | n/a |
| Delta Asia International Corporation · TPEX:6762 | US$151.3M | US$152.0M | 213× | 7.2× | 18.2× | 3.8× | 3.4% | 0.2× | n/a |
| KORU Medical Systems, Inc. · NASDAQ:KRMD | US$147.3M | US$3.17T | n/a | 68,440× | 15,926,569× | 7.6× | −1.8% | 163,275× | 1.06 |
| Nextbiomedical Co. Ltd. · KRX:389650 | US$146.4M | US$120.9M | 847× | 9.1× | n/a | 4.0× | 1.3% | 0.0× | n/a |
| Paxman AB · OMXSTO:PAX | US$146.2M | US$137.1M | n/a | 3.8× | 36.9× | 3.6× | −1.4% | 0.0× | n/a |
| TriSalus Life Sciences, Inc. · NASDAQ:TLSI | US$143.1M | US$134.5M | n/a | 2.9× | n/a | 211× | −56.6% | 47.6× | 1.22 |
| Asterasys Co., Ltd. · KRX:450950 | US$138.3M | US$124.7M | 30.6× | 4.2× | 26.8× | 4.1× | 15.4% | 0.0× | n/a |
| Hans Biomed Corp · KRX:042520 | US$135.1M | US$125.0M | n/a | 1.4× | n/a | 2.3× | −15.8% | 0.1× | n/a |
| MicroTech Medical (Hangzhou) Co., Ltd. Class H · HKEX:2235 | US$127.9M | −US$86.42M | 21.2× | −0.9× | −10.0× | 0.4× | 6.1% | 0.1× | n/a |
| Median of the others | US$146.3M | US$129.0M | 33.9× | 3.4× | 26.8× | 3.7× | 2.4% | 0.0× | 1.14 |
Forecasts
1 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 10.75 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.29 · 1 analyst
- Revenue, year to Dec 2026
- 311.3M · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Kevin R.M. Smith | General Counsel and Executive Vice President, Business Development |
| Jason Richardson | Chief Financial Officer |
| Andy Reding | Chief Operating Officer |
| Jennifer Yi Boyer | Executive Vice President, Enterprise Enablement and Chief Human Resources Officer |
| Paul Andreassi | Executive Vice President, Chief Quality and Regulatory Affairs Officer |
| Philip Corrin | Senior Vice President, Operations and Supply Chain |
| Dominic Hulton | Chief Marketing Officer |
| Krishna Jhaveri | Chief Medical Officer |
| Naga Rameswamy | Chief Technology Officer |
Board
| Director | Role |
|---|---|
| Elizabeth Mora | Chairperson of the Board |
| Glenn Boehnlein | Director |
| Heather D. Rider | Director |
| Kevin King | Director |
| Kevin R.M. Smith | General Counsel and Executive Vice President, Business Development |
| Mary Katherine Ladone | Director |
| Mira Sahney | Director |
| Vafa Jamali | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Inogen (NASDAQ:INGN) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q2 2026 Earnings Call | Thu, Aug 06, 2026 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q1 2026 Earnings Call | Thu, May 07, 2026 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q4 2025 Earnings Call | Tue, Feb 24, 2026 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q3 2025 Earnings Call | Wed, Nov 05, 2025 · 8:30 AM ET | Replay |
| Inogen (NASDAQ:INGN) Q2 2025 Earnings Call | Thu, Aug 07, 2025 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q1 2025 Earnings Call | Wed, May 07, 2025 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q4 2024 Earnings Call | Tue, Feb 25, 2025 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q3 2024 Earnings Call | Thu, Nov 07, 2024 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q2 2024 Earnings Call | Tue, Aug 06, 2024 · 5:00 PM ET | Replay |
All 22 calls
| Call | When | Status |
|---|---|---|
| Inogen (NASDAQ:INGN) Q1 2024 Earnings Call | Tue, May 07, 2024 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q4 2023 Earnings Call | Tue, Feb 27, 2024 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q3 2023 Earnings Call | Tue, Nov 07, 2023 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q2 2023 Earnings Call | Mon, Aug 07, 2023 · 4:30 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q1 2023 Earnings Call | Thu, May 04, 2023 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q4 2022 Earnings Call | Thu, Feb 23, 2023 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q3 2022 Earnings Call | Wed, Nov 02, 2022 · 8:30 AM ET | Replay |
| Inogen (NASDAQ:INGN) Q2 2022 Earnings Call | Thu, Aug 04, 2022 | Replay |
| Inogen (NASDAQ:INGN) Q1 2022 Earnings Call | Thu, May 05, 2022 · 7:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q4 2021 Earnings Call | Thu, Feb 24, 2022 · 5:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 7:00 PM ET | Replay |
| Inogen (NASDAQ:INGN) Q2 2021 Earnings Call | Wed, Aug 04, 2021 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · After close | −10.9% |
| Q2 2026 | Aug 6, 2026 · After close | −6.8% |
| Q1 2026 | May 7, 2026 · After close | −2.4% |
| Q4 2025 | Mar 3, 2026 | +2.1% |
| Q3 2025 | Nov 5, 2025 · Before open | −8.3% |
| Q2 2025 | Aug 7, 2025 · After close | +10.4% |
| Q1 2025 | May 7, 2025 · After close | −11.4% |
| Q4 2024 | Feb 25, 2025 · Before open | −3.3% |
| Q3 2024 | Nov 7, 2024 · After close | +17.2% |
| Q2 2024 | Aug 6, 2024 · After close | +36.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 7, 2024 · After close | +12.9% |
| Q4 2023 | Feb 27, 2024 · After close | −32.7% |
| Q3 2023 | Nov 7, 2023 · After close | −1.1% |
| Q2 2023 | Aug 7, 2023 · After close | −13.6% |
| Q1 2023 | May 4, 2023 · After close | −5.4% |
| Q4 2022 | Feb 23, 2023 · After close | −31.4% |
| Q3 2022 | Nov 2, 2022 · Before open | −7.8% |
| Q2 2022 | Aug 4, 2022 · After close | −3.3% |
| Q1 2022 | May 5, 2022 · After close | +3.5% |
| Q4 2021 | Feb 24, 2022 · After close | +5.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2026) | Investor deck | 18 slides | Nov 5, 2026 |
| Investor Presentation (August 2026) | Investor deck | 19 slides | Aug 6, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 9 slides | Aug 6, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 8 slides | May 7, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 10 slides | Feb 24, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 8 slides | Nov 5, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 22 slides | Aug 7, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 8 slides | May 7, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 9 slides | Feb 25, 2025 |
| Q3 2024 Earnings Presentation | Earnings | 8 slides | Nov 7, 2024 |
All 26 decks
Financings
| Raise | Date |
|---|---|
| Strategic investment of common equity Announced: about US$27.2M Buyers: Yuwell (approximately $27.2 million, representing a 9.9% common equity interest, through its affiliate) Use of proceeds: Cement the collaboration with Yuwell and bolster Inogen's balance sheet | Jan 26, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$16.00 a share on Feb 13, 2014.
- Price
- US$16.00 a share
- Shares offered
- 4,411,763 shares of common stock · 3,529,411 from the company and 882,352 from selling shareholders
- Offering size
- US$70.6 million
- Underwriters' option
- Up to 661,764 more shares
- Underwriters
- J.P. Morgan, Leerink Partners, William Blair, Stifel · In the order on the cover
- Shares delivered
- On or about Feb 20, 2014
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Oct 16, 2013 |
| Filed publicly | Nov 27, 2013 |
| Amended 5 times | Newest Feb 12, 2014 |
| Shares registered with an exchange | Feb 10, 2014 |
| Declared effective by the SEC | Feb 12, 2014 |
| Final prospectus, with the price | Feb 14, 2014 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Feb 14, 2014 |
| EFFECT · Notice that a registration is effective | Feb 12, 2014 |
| UPLOAD · Letter from the SEC | Feb 12, 2014 |
| FWP · Free writing prospectus | Feb 12, 2014 |
| CORRESP · Letter to the SEC | Feb 12, 2014 |
| CORRESP · Letter to the SEC | Feb 12, 2014 |
| S-1/A · Registration statement, amended | Feb 12, 2014 |
| CORRESP · Letter to the SEC | Feb 11, 2014 |
| UPLOAD · Letter from the SEC | Feb 11, 2014 |
| 8-A12B · Registration of shares for listing on an exchange | Feb 10, 2014 |
All 25 filings
| Filing | Filed |
|---|---|
| S-1/A · Registration statement, amended | Feb 4, 2014 |
| CORRESP · Letter to the SEC | Feb 3, 2014 |
| UPLOAD · Letter from the SEC | Feb 3, 2014 |
| CORRESP · Letter to the SEC | Jan 31, 2014 |
| CORRESP · Letter to the SEC | Jan 30, 2014 |
| S-1/A · Registration statement, amended | Jan 28, 2014 |
| UPLOAD · Letter from the SEC | Jan 27, 2014 |
| S-1/A · Registration statement, amended | Jan 16, 2014 |
| CORRESP · Letter to the SEC | Jan 13, 2014 |
| UPLOAD · Letter from the SEC | Jan 9, 2014 |
| S-1/A · Registration statement, amended | Dec 23, 2013 |
| UPLOAD · Letter from the SEC | Dec 13, 2013 |
| S-1 · Registration statement | Nov 27, 2013 |
| UPLOAD · Letter from the SEC | Nov 13, 2013 |
| DRS · Draft registration statement | Oct 16, 2013 |
Open IPO · From the cover of the final prospectus (424B4) filed Feb 14, 2014
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 348.7M | 335.7M | 315.7M | 377.2M | 358.0M | 308.5M | 361.9M | 358.1M | 249.4M | 202.8M |
| Cost of revenue | 194.4M | 181.0M | 189.0M | 223.7M | 181.5M | 170.3M | 190.1M | 179.5M | 128.2M | 105.5M |
| Gross profit | 154.3M | 154.7M | 126.7M | 153.5M | 176.5M | 138.2M | 171.9M | 178.6M | 121.2M | 97.3M |
| Research and development | 19.4M | 21.6M | 20.8M | 21.9M | 16.6M | 14.1M | 9.40M | 7.03M | 5.31M | 5.11M |
| Selling, general and administrative | 67.4M | 72.6M | 75.3M | 43.9M | 37.9M | 38.6M | 37.1M | 38.0M | 37.6M | 31.8M |
| Operating income | -30.2M | -42.5M | -109.4M | -85.2M | 9.24M | -12.0M | 19.8M | 37.9M | 27.6M | 22.9M |
| Depreciation and amortization | 20.7M | 21.0M | 18.2M | 23.5M | 21.6M | 18.6M | 13.8M | 11.3M | 12.3M | 13.6M |
| EBITDA | -9.55M | -21.5M | -91.2M | -61.7M | 30.9M | 6.56M | 33.6M | 49.2M | 39.9M | 36.4M |
| Interest expense | 2.84M | 21.0M | 25.3M | 18.3M | 0 | 0 | 6.00K | |||
| Income before tax | -23.4M | -36.5M | -102.3M | -83.3M | 8.66M | -5.28M | 24.3M | 40.5M | 29.7M | 22.7M |
| Income tax | -632.0K | -588.0K | 105.0K | 504.0K | 15.0M | 549.0K | 3.32M | -11.4M | 8.65M | 2.21M |
| Net income | -22.7M | -35.9M | -102.4M | -83.8M | -6.33M | -5.83M | 20.9M | 51.8M | 21.0M | 20.5M |
| Earnings per share, basic | -0.86 | -1.52 | -4.42 | -3.67 | -0.28 | -0.27 | 0.96 | 2.44 | 1.02 | 1.02 |
| Earnings per share, diluted | -0.86 | -1.52 | -4.42 | -3.67 | -0.28 | -0.27 | 0.94 | 2.30 | 0.96 | 0.97 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 103.7M | 113.8M | 125.5M | 187.0M | 235.5M | 212.0M | 198.0M | 196.6M | 143.0M | 92.9M |
| Short-term investments | 15.8M | 0 | 2.98M | 0 | 9.99M | 19.3M | 11.1M | 43.7M | 31.0M | 21.0M |
| Receivables | 34.1M | 29.6M | 42.2M | 62.7M | 24.5M | 29.7M | 34.3M | 37.0M | 31.4M | 30.8M |
| Inventory | 26.0M | 24.8M | 21.8M | 34.1M | 31.9M | 24.8M | 35.7M | 27.1M | 18.8M | 14.3M |
| Current assets | 224.6M | 185.5M | 207.1M | 304.6M | 329.2M | 305.7M | 292.2M | 314.6M | 228.5M | 161.5M |
| Property, plant and equipment | 10.1M | 44.4M | 50.3M | 43.3M | 38.9M | 28.2M | 19.4M | 22.3M | 20.1M | 25.2M |
| Goodwill | 10.7M | 9.46M | 10.1M | 32.9M | 33.0M | 33.2M | 33.0M | 2.26M | 2.36M | 0 |
| Total assets | 298.6M | 296.2M | 326.2M | 405.0M | 489.5M | 461.9M | 447.3M | 375.9M | 275.1M | 214.0M |
| Accounts payable | 19.7M | 16.6M | 13.5M | 18.2M | 10.3M | 12.5M | 16.4M | 13.7M | 9.54M | 5.74M |
| Current liabilities | 63.5M | 76.7M | 72.5M | 65.3M | 61.5M | 56.7M | 50.2M | 46.6M | 33.9M | 22.8M |
| Long-term debt | 0 | 0 | ||||||||
| Total debt | 17.5M | 19.4M | 21.9M | 23.3M | 26.7M | 10.0M | 6.72M | |||
| Total liabilities | 106.4M | 122.3M | 121.4M | 107.6M | 119.3M | 112.2M | 102.7M | 65.5M | 48.0M | 32.0M |
| Shareholders' equity | 192.2M | 173.9M | 204.8M | 297.4M | 370.2M | 349.6M | 344.6M | 310.4M | 227.0M | 182.1M |
| Shares outstanding | 27.2M | 23.9M | 23.3M | 22.9M | 22.7M | 22.1M | 22.0M | 21.8M | 21.0M | 20.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -11.2M | 5.91M | -3.23M | -37.5M | 23.6M | 37.0M | 40.6M | 60.0M | 60.5M | 31.0M |
| Capital spending | -2.52M | -3.36M | -5.22M | -3.34M | -5.48M | -4.38M | -3.14M | -8.04M | -2.91M | -1.72M |
| Free cash flow | -13.7M | 2.55M | -8.45M | -40.9M | 18.2M | 32.6M | 37.5M | 51.9M | 57.6M | 29.3M |
| Cash from investing | -26.2M | -14.0M | -59.3M | -10.9M | -14.6M | -25.6M | -44.1M | -25.0M | -24.4M | -11.9M |
| Cash from financing | 24.2M | 265.0K | 960.0K | 380.0K | 15.0M | 2.07M | 4.93M | 18.3M | 14.0M | 7.71M |
| Dividends paid | 0 | 0 | ||||||||
| Share buybacks | -546.0K | -518.0K | -1.35M | -647.0K | -350.0K | -928.0K | -1.21M | 14.0M | 8.03M | |
| Change in cash | -12.4M | -8.08M | -61.5M | -48.5M | 23.6M | 13.9M | 1.40M | 53.7M | 50.1M | 26.7M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 19, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 9, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| 8-K · Current report | Sep 30, 2026 | Material contract | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 7, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2026 | Results | SEC |
| S-8 · Registration statement for employee plans | Jul 24, 2026 | Offer document | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Jul 9, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 1, 2026 | Other filings | SEC |
| 8-K · Current report | Jul 1, 2026 | Management or board change | SEC |
| S-8 · Registration statement for employee plans | Jun 12, 2026 | Offer document | SEC |
| 8-K · Current report | Jun 11, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 29, 2026 | Other filings | SEC |
| SD · Specialized disclosure | May 28, 2026 | ESG report | SEC |
| 10-Q · Quarterly report | May 8, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2026 | Results | SEC |
| S-8 · Registration statement for employee plans | May 4, 2026 | Offer document | SEC |
| ARS · Annual report to shareholders | Apr 28, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 28, 2026 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 17, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 8, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 8, 2026 | Insider trade | SEC |
| 8-K · Current report | Apr 6, 2026 | Material contract | SEC |
| 8-K · Current report | Mar 30, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Feb 27, 2026 | Offer document | SEC |
| 10-K · Annual report | Feb 27, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2026 | Results | SEC |
| 8-K · Current report | Jan 12, 2026 | Results | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2025 | Results | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 3, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 8, 2025 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Aug 7, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Aug 7, 2025 | Results | SEC |
| 8-K · Current report | Jul 29, 2025 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 17, 2025 | Big-stake notice | SEC |
| SD · Specialized disclosure | May 29, 2025 | ESG report | SEC |
| S-8 · Registration statement for employee plans | May 20, 2025 | Offer document | SEC |
| 8-K · Current report | May 19, 2025 | Management or board change | SEC |
| 4 · Change in ownership | May 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 8, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2025 | Results | SEC |
| ARS · Annual report to shareholders | Mar 27, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 27, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 27, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 4, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Feb 28, 2025 | Offer document | SEC |
| 10-K · Annual report | Feb 28, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 25, 2025 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 24, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 4, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 4, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 3, 2025 | Management or board change | SEC |
| 8-K · Current report | Jan 27, 2025 | Material contract | SEC |
| 8-K · Current report | Jan 13, 2025 | Results | SEC |
| 8-K · Current report | Dec 30, 2024 | Current report | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 3/A · Initial statement of ownership, amended | Dec 3, 2024 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 8, 2024 | Quarterly report | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 8, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Nov 7, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Oct 22, 2024 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | Aug 9, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2024 | Results | SEC |
| 8-K · Current report | Jul 31, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Jul 24, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 24, 2024 | Insider trade | SEC |
| 8-K · Current report | Jul 3, 2024 | Management or board change | SEC |
| S-8 · Registration statement for employee plans | Jun 12, 2024 | Offer document | SEC |
| 4 · Change in ownership | Jun 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 7, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 7, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Jun 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 7, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 4, 2024 | Insider trade | SEC |
| SD · Specialized disclosure | May 31, 2024 | ESG report | SEC |
| 8-K · Current report | May 15, 2024 | Management or board change | SEC |
| 144 · Notice of proposed sale | May 14, 2024 | Other filings | SEC |
| 4 · Change in ownership | May 14, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 8, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2024 | Results | SEC |
| 4 · Change in ownership | May 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 3, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Apr 23, 2024 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 18, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 18, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 18, 2024 | Meeting notice | SEC |
| 8-K · Current report | Apr 15, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Mar 6, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 5, 2024 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Mar 1, 2024 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Mar 1, 2024 | Offer document | SEC |
| 10-K · Annual report | Mar 1, 2024 | Annual report | SEC |
| 8-K · Current report | Feb 27, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jan 24, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 24, 2024 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Jan 11, 2024 | Insider trade | SEC |
| 8-K · Current report | Jan 5, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Dec 4, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2023 | Insider trade | SEC |
| 8-K · Current report | Nov 27, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Nov 13, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 13, 2023 | Insider trade | SEC |
| 8-K · Current report | Nov 13, 2023 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 9, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 7, 2023 | Results | SEC |
| 8-K · Current report | Sep 18, 2023 | Acquisition or disposal | SEC |
| 3 · Initial statement of ownership | Sep 15, 2023 | Insider trade | SEC |
| 8-K · Current report | Sep 7, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Sep 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 5, 2023 | Insider trade | SEC |
| 8-K · Current report | Aug 11, 2023 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 8, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 7, 2023 | Results | SEC |
| 8-K · Current report | Jul 31, 2023 | Management or board change | SEC |
| SC 13G · Big-stake notice | Jul 24, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Jul 18, 2023 | Material contract | SEC |
| 8-K · Current report | Jul 13, 2023 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Jul 10, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Jul 7, 2023 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Jun 6, 2023 | Offer document | SEC |
| 8-K · Current report | Jun 5, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Jun 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2023 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2023 | ESG report | SEC |
| DEFA14A · Additional proxy material | May 11, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 5, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 4, 2023 | Results | SEC |
| DEFA14A · Additional proxy material | Apr 28, 2023 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Apr 18, 2023 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 18, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 18, 2023 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 4, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 4, 2023 | Insider trade | SEC |
| 8-K · Current report | Mar 22, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Mar 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 2, 2023 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Feb 24, 2023 | Offer document | SEC |
| 10-K · Annual report | Feb 24, 2023 | Annual report | SEC |
| 8-K · Current report | Feb 23, 2023 | Results | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Inogen, Inc’s releases · as of Jan 26, 2025
- Common shares
- 26,538,337
- Fully diluted
- 26,538,337
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 26,538,337 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 26,538,337 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| William J. Link Other companies: RxSight, Inc. (Director · Since at least Jul 29, 2021); Tarsus Pharmaceuticals, Inc. (Director · Since at least Oct 15, 2020); LENSAR, Inc. (Director · Since at least Sep 17, 2020); Oyster Point Pharma Inc (Director · Oct 30, 2019 – Jan 5, 2022 · Past); Glaukos Corporation (Director · Jun 24, 2015 – Jun 3, 2021 · Past); Vivani Medical, Inc. (Director · Nov 18, 2014 – Jun 4, 2019 · Past); Flexion Therapeutics Inc (Director · Sep 10, 2014 – Sep 10, 2014 · Past); Edwards Lifesciences Corporation (Director · May 15, 2013 – May 8, 2020 · Past) | Director · Feb 12, 2014 – Feb 20, 2014 · Past |
| Elizabeth Mora Other companies: Allbirds, Inc. (Director · Since at least Oct 1, 2026); Limoneira Co (Director · Since at least Nov 1, 2021); MKS Inc. (Director · Since at least May 7, 2012); Nuburu, Inc. (Director · Jan 31, 2023 – Aug 31, 2023 · Past); Everest Consolidator Acquisition Corporation (Director · Nov 23, 2021 – Nov 23, 2021 · Past); GCP Applied Technologies Inc (Director · Feb 3, 2016 – Jun 1, 2020 · Past) | Chairperson of the Board · Since at least May 24, 2021 |
| Thomas A. West Other companies: CeriBell, Inc. (Director · Since at least Jul 28, 2026); SI-BONE, Inc. (Director · Since at least Jun 25, 2024); Orthofix Medical Inc. (Director · Dec 13, 2021 – Dec 31, 2022 · Past); Intersect ENT Inc (President and CEO, Director · Jul 22, 2019 – May 13, 2022 · Past); Hologic Inc (Div President & GM, Diagnostic · Oct 3, 2014 – Dec 1, 2018 · Past) | Director · Apr 1, 2023 – Jun 5, 2024 · Past |
| Mary Kay Ladone Other companies: Kestra Medical Technologies, Ltd. (Director · Since at least Mar 6, 2025); Novanta Inc. (Director · Since at least Jul 11, 2024); Bioventus Inc. (Director · Since at least Jul 15, 2021); Hill-Rom Holdings Inc (SVP, Corp. Dev., Strat. & IR · Dec 3, 2018 – Dec 13, 2021 · Past) | Director · Since at least Mar 22, 2022 |
| R. Scott Greer Other companies: Nektar Therapeutics (Managing Director, Numenor Ventures, LLC · Since at least Sep 15, 2015); Microbot Medical Inc. (Director · Jan 1, 2016 – Jan 1, 2016 · Past); Aravive Inc (Director · Jun 29, 2015 – Dec 20, 2017 · Past); Sientra Inc (Director · Jun 26, 2015 – Jun 5, 2018 · Past) | Director · Aug 3, 2015 – May 10, 2021 · Past |
| Glenn Boehnlein Other companies: DexCom, Inc. (Director · Since at least Sep 10, 2026); Agilent Technologies, Inc. (Director · Since at least Sep 4, 2026); Stryker Corporation (VP, Chief Financial Officer · Apr 1, 2016 – Mar 21, 2025 · Past) | Director · Since at least Mar 22, 2022 |
| Heath Lukatch Other companies: Vaxcyte, Inc. (Director · Since at least Jun 11, 2020); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 8, 2023 · Past); Flexion Therapeutics Inc (Director · Feb 11, 2014 – Nov 19, 2021 · Past) | Director · Feb 12, 2014 – May 10, 2021 · Past |
| Alison Bauerlein Other companies: Sight Sciences, Inc. (Chief Operating Officer · Since at least Apr 3, 2023); Pear Therapeutics Inc (Director · Dec 3, 2021 – Feb 15, 2023 · Past) | EVP, Finance, & CFO · Mar 31, 2016 – Dec 1, 2021 · Past |
| Michael J Bourque Other companies: Chase Corporation (Treasurer & CFO · Feb 2, 2021 – Nov 15, 2023 · Past); Analogic Corporation (See Remarks · Apr 24, 2015 – Jun 22, 2018 · Past) | EVP, CFO & Treasurer · Since at least Mar 4, 2024 |
| Raymond O. Huggenberger Other companies: Tactile Systems Technology, Inc. (Director · Since at least Sep 20, 2017); IntriCon Corporation (Director · Apr 26, 2019 – May 24, 2022 · Past) | Director · Feb 12, 2014 – Sep 15, 2021 · Past |
All 46 people
| Person | Seat |
|---|---|
| Andy Reding Other companies: Axe Compute Inc. (Director · Oct 19, 2009 – Jun 30, 2020 · Past) | Chief Operating Officer · Since at least Jul 1, 2026 |
| Brenton Taylor Other companies: Sight Sciences, Inc. (EVP, Operations & R&D · Since at least Nov 4, 2024) | EVP, Engineering · Feb 12, 2014 – Sep 28, 2021 · Past |
| Gregoire Ramade Other companies: Vapotherm Inc (SVP & Chief Commercial Officer · Jan 1, 2020 – Jan 2, 2023 · Past) | Chief Commercial Officer · Since at least Jan 2, 2024 |
| Heather D. Rider Other companies: IntriCon Corporation (Director · Mar 20, 2020 – May 24, 2022 · Past) | Director · Since at least Aug 6, 2014 |
| Jason Richardson Other companies: Hill-Rom Holdings Inc (Corporate Controller · Mar 14, 2016 – Nov 18, 2017 · Past) | Chief Financial Officer · Since at least Mar 30, 2026 |
| Kevin King Other companies: iRhythm Holdings, Inc. (Director · Oct 19, 2016 – Mar 4, 2022 · Past) | Director · Since at least Mar 22, 2022 |
| Loren L McFarland Other companies: Mentor Corp (CFO · Jun 13, 2006 – Oct 5, 2007 · Past) | Director · Feb 12, 2014 – Jan 11, 2022 · Past |
| Michael K Sergesketter Other companies: Kimball Electronics, Inc. (Vice President · Oct 7, 2014 – Aug 24, 2020 · Past) | EVP, CFO, and Treasurer · Dec 13, 2021 – Sep 11, 2023 · Past |
| Nabil Shabshab Other companies: Becton, Dickinson and Company (Executive Vice President · Jan 29, 2013 – May 11, 2018 · Past) | CEO and President, Director · Feb 8, 2021 – Sep 1, 2023 · Past |
| Ray Benjamin M Anderson Other companies: Chromcraft Revington Inc (Chairman and CEO, Director · Sep 26, 2007 – Sep 26, 2007 · Past) | Director · Feb 12, 2014 – Mar 3, 2022 · Past |
| Timothy Petersen Other companies: SI-BONE, Inc. (Director · Oct 16, 2018 – Oct 19, 2018 · Past) | Director · Feb 12, 2014 – May 29, 2015 · Past |
| Vafa Jamali Other companies: ZimVie Inc (See remarks below., Director · Since at least Feb 7, 2022) | Director · Since at least Apr 6, 2026 |
| Arron Retterer | EVP, Sales · Aug 17, 2020 – Mar 1, 2021 · Past |
| Bart Ben Sanford | EVP, Operations · Sep 17, 2018 – Mar 1, 2023 · Past |
| Boyer Jennifer M Yi | EVP Entrprs Enblmnt, Ch HR Off · Since at least Jul 28, 2025 |
| Byron Myers | EVP, Marketing · Feb 12, 2014 – Mar 15, 2021 · Past |
| Charles E Larsen | Director · Feb 12, 2014 – Apr 1, 2014 · Past |
| Dominic Hulton | Chief Marketing Officer · Since at least Mar 30, 2026 |
| George J Parr | Chief Commercial Officer · Apr 12, 2021 – Jun 1, 2023 · Past |
| Jason Somer | EVP, Gen. Counsel & Secretary · Jul 12, 2021 – Jun 1, 2024 · Past |
| Jennifer Yi Boyer | Executive Vice President, Enterprise Enablement and Chief Human Resources Officer · Since at least Nov 5, 2026 |
| Kevin P Smith | EVP, Bus Dev, GC & Sec · Since at least Jul 22, 2024 |
| Kevin R.M. Smith | General Counsel and Executive Vice President, Business Development · Since at least Nov 10, 2023 |
| Krishna Jhaveri | Chief Medical Officer · Since at least Nov 5, 2026 |
| Kristen Miranda | Director · Mar 1, 2021 – Jun 8, 2022 · Past |
| Kristin A Caltrider | EVP, CFO and Treasurer · Mar 21, 2022 – Feb 28, 2023 · Past |
| Mary E Wright | VP, Chief Accounting Officer · Since at least Jul 28, 2025 |
| Matt Scribner | EVP, Operations · Feb 12, 2014 – Sep 1, 2018 · Past |
| Mira Kirti Sahney | Director · Since at least Jan 31, 2025 |
| Naga Rameswamy | Chief Technology Officer · Since at least Sep 25, 2025 |
| Paul Andreassi | Executive Vice President, Chief Quality and Regulatory Affairs Officer · Since at least Nov 5, 2026 |
| Philip Corrin | Senior Vice President, Operations and Supply Chain · Since at least Nov 5, 2026 |
| Scott Beardsley | Director · Jan 1, 2017 – Jan 1, 2017 · Past |
| Scott Wilkinson | President and CEO, Director · Feb 12, 2014 – Dec 1, 2020 · Past |
| Stanislav Glezer | EVP, R&D & Chief Med. Officer · Jun 21, 2021 – May 1, 2024 · Past |
| Stephen E Cooper | Director · Feb 12, 2014 – Feb 20, 2014 · Past |
Log in to ask 6ix AI your own questions about Inogen, Inc.